Funding for this research was provided by:
Grand Challenges Canada
Received: 22 June 2020
Accepted: 18 August 2020
First Online: 27 August 2020
Ethics approval and consent to participate
: The study protocol was approved by the Institutional Review Board (IRB) of Institute of Jimma University (IHRPGD/3027/18)) and the University of Calgary Conjoint Health Research Ethics Board (REB 17-1335). Permission to conduct the study was obtained from Bonga Zone Health Bureau. Informed consent was obtained from all individuals prior to study participation. Patients diagnosed positive for malaria were treated according to Federal Ministry of Health (Ethiopia) national treatment guidelines.
: Not applicable.
: DRP is an Associate Editor of Malaria Journal and Scientific Advisor to Illucidx Inc. that has patents related to LAMP technology. CD is an employee of Illucidx Inc.